$CORT insiders have traded $CORT stock on the open market 23 times in the past 6 months. Of those trades, 0 have been purchases and 23 have been sales.

Corcept (CORT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Shares of Corcept Therapeutics Incorporated CORT were up a staggering 109.1% on March 31 after the company announced data from the phase III ROSELLA study, which evaluated its pipeline candidate ...

CORT) stands against the other best performing pharma stocks so far in 2025. On February 20, Jared Holz, Mizuho healthcare ...